Insider Transactions in Q3 2021 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 02
2021
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
500,000
+19.76%
|
$7,000,000
$14.0 P/Share
|
|
Jul 02
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
1,530,691
+50.0%
|
-
|
|
Jul 02
2021
|
Atlas Venture Fund Xii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
535,714
+14.72%
|
$7,499,996
$14.0 P/Share
|
|
Jul 02
2021
|
Atlas Venture Fund Xii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,568,165
+50.0%
|
-
|
|
Jul 02
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
357,142
+8.68%
|
$4,999,988
$14.0 P/Share
|
|
Jul 02
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,401,544
+50.0%
|
-
|
|
Jul 02
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
5,236,801
+49.5%
|
-
|
|
Jul 02
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,785,714
+28.57%
|
$38,999,996
$14.0 P/Share
|
|
Jul 02
2021
|
David S. Grayzel |
BUY
Open market or private purchase
|
Indirect |
535,714
+14.72%
|
$7,499,996
$14.0 P/Share
|
|
Jul 02
2021
|
David S. Grayzel |
BUY
Conversion of derivative security
|
Indirect |
2,568,165
+50.0%
|
-
|
|
Jul 02
2021
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
357,142
+8.68%
|
$4,999,988
$14.0 P/Share
|
|
Jul 02
2021
|
Maha Katabi |
BUY
Conversion of derivative security
|
Indirect |
3,401,544
+50.0%
|
-
|